David K. Gieser - Concepedia

Author

David K. Gieser

University of Illinois Chicago

Also Known As

D K Gieser, D. Gieser, D. K. Gieser, David Gieser, David K Gieser, David K. Gieser, David P Gieser

Publications

2.4K

Citations

H-Index

Concepts

All Affiliations

University of Illinois Chicago Wheaton College - Illinois New York Eye and Ear Infirmary Washington University in St. Louis Northwestern University

About

David K. Gieser is an author at University of Illinois Chicago specializing in medicine, ophthalmology, and glaucoma.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	16	18	1.2K
2	Education	2	2	104
3	Health Sciences	1	1	10
4	Anatomy	1	1	42
5	Civil Engineering	1	1	36

David K. Gieser

Publications

2.3K

Citations

H-Index

Page 1

	Year	Citations
Large Diurnal Fluctuations in Intraocular Pressure Are an Independent Risk Factor in Patients With Glaucoma Sanjay Asrani, R. Zeimer, Jacob T. Wilensky, Journal of Glaucoma	2000	888
Follow-up of Angle-closure Glaucoma Suspects Jacob T. Wilensky, Paul L. Kaufman, Diane Frohlichstein, American Journal of Ophthalmology Ocular DiseaseOphthalmologyGlaucomaAngle-closure Glaucoma SuspectsMedicine	1993	162
Association between Intraocular Pressure Peaks and Progression of Visual Field Loss R. Zeimer, Jacob T. Wilensky, David K. Gieser, Ophthalmology Ocular DiseaseRetinaOphthalmologyIntraocular Pressure PeaksVisual Field Loss	1991	156
Individual Variability in the Diurnal Intraocular Pressure Curve Jacob T. Wilensky, David K. Gieser, Mary Lynn Dietsche, Ophthalmology SleepHypertensionOphthalmologyPhysiological OpticIndividual Variability	1993	151
A randomized trial comparing the dorzolamide-timolol combination given twice daily to monotherapy with timolol and dorzolamide11Ms. Boyle, Dr. Ghosh, and Dr. Adamsons were employees of Merck & Co., Inc, the manufacturer of timolol and dorzolamide, at the time this study was conducted. COSOPT and TRUSOPT are trademark products of Merck & Co., Inc, Whitehouse Station, New Jersey. The other authors have no proprietary interest in timolol, dorzolamide, or Merck. Janet E Boyle, Kalyan Ghosh, David K. Gieser, Ophthalmology Medicinal ChemistryClinical TherapeuticMedicineMetronomic TherapyDorzolamide-timolol Combination	1998	149
Central Corneal Endothelial Cell Density and Central Corneal Thickness in Ocular Hypertension and Primary Open-Angle Glaucoma Michael Korey, David K. Gieser, Michael A. Kass, American Journal of Ophthalmology Ocular DiseaseOphthalmologyExperimental OphthalmologyCentral Corneal ThicknessGlaucoma	1982	88
5-Fluorouracil in Initial Trabeculectomy Mordechai Goldenfeld, Theodore Krupin, Jon M. Ruderman, Ophthalmology Surgical OncologyMinimally Invasive ProcedureSurgeryTrabecular MeshworkMedicine	1994	87
Acetazolamide and Urolithiasis Michael A. Kass, Allan E. Kolker, Mae O. Gordon, Ophthalmology Medicinal ChemistryUrologyUrological ResearchAntiparasitic AgentMedicine	1981	73
Presence and Rapid Decline of Early Morning Intraocular Pressure Peaks in Glaucoma Patients R. Zeimer, Jacob T. Wilensky, David K. Gieser Ophthalmology HypertensionOcular DiseaseOphthalmologyRapid DeclineEye Health	1990	72
Self-Tonometry to Manage Patients With Glaucoma and Apparently Controlled Intraocular Pressure Jacob T. Wilensky, David K. Gieser, Marek Mori, Archives of Ophthalmology Normal SubjectsHypertensionOcular DiseaseOphthalmologyMeasurement	1987	68

Page 1